scholarly journals The Evolution of COVID ‐19 Vaccination Within a US Blood Center

Transfusion ◽  
2021 ◽  
Author(s):  
Ralph R. Vassallo ◽  
Hany Kamel ◽  
Larry J. Dumont ◽  
Marjorie D. Bravo
Keyword(s):  
2017 ◽  
Vol 56 (2) ◽  
pp. 130-134 ◽  
Author(s):  
Aline G. Monich ◽  
Tiago W. Dantas ◽  
Karla B. Fávero ◽  
Paulo T.R. Almeida ◽  
Eliane C. Maluf ◽  
...  
Keyword(s):  

Transfusion ◽  
1991 ◽  
Vol 31 (6) ◽  
pp. 509-512 ◽  
Author(s):  
GF Giordano ◽  
J Dockery ◽  
BA Wallace ◽  
KM Donohoe ◽  
SL Rivers ◽  
...  

2013 ◽  
Vol 35 (1) ◽  
pp. 23-28 ◽  
Author(s):  
Adriana Aparecida Ferreira ◽  
Maria Teresa Bustamante-Teixeira ◽  
Isabel Cristina Gonçalves Leite ◽  
Camila Soares Lima Corrêa ◽  
Daniela de Oliveira W. Rodrigues ◽  
...  

Transfusion ◽  
2013 ◽  
pp. n/a-n/a ◽  
Author(s):  
Felipe Baesler ◽  
Matías Nemeth ◽  
Cristina Martínez ◽  
Alfonso Bastías

2013 ◽  
Vol 55 (4) ◽  
pp. 245-250 ◽  
Author(s):  
Elaine Cristina Navarro ◽  
Renata Leme Goto ◽  
Isabella Silva Ricoboni ◽  
Jose Eduardo Corrente ◽  
Rita Maria Saccomano Henriques ◽  
...  

SUMMARY This study aimed at estimating the number of cases of non-negative serological reactions to Chagas disease in blood donors at the Blood Center of Botucatu, São Paulo, Brazil, from 2003 to 2010 and at relating them to their cities of origin. Five hundred and seventy-four non-negative results for Chagas disease were evaluated. Of these, 371 (64.8%) were reagent, and 203 (35.4%) were inconclusive. The prevalence of Chagas disease in blood donors was 0.05%. There were, on average, 72 cases/year, and a prevalence of males was observed (64.8%). Forty-three (7.49%) individuals were 18 to 30 years old; 92 (16.02%) were 31 to 40; 147 (25.61%) 41 to 50, and 292 (50.87%) were older than 50 years. It was observed that 29.3% of females with reagent serology were at their fertile age (18 and 45 years). The majority of donors were originally from cities in the southwestern and central regions of São Paulo, but individuals from other states contributed with 20%. The provenance of most donors was the city of Botucatu/SP, followed by the city of Taquarituba/SP. Therefore, the profile of donors at this blood center favors the occurrence of a larger number of non-negative serological reactions. Although there has been a significant reduction in the number of new cases/year for this disease, it is still a public-health problem, and results suggest the need for new epidemiological assessments in the studied region.


2020 ◽  
Author(s):  
LING LI ◽  
YING LI ◽  
Shaofang Lu ◽  
Jing Dong ◽  
Haixia Xu ◽  
...  

Abstract BACKGROUND Dengue virus (DENV) can be transmitted through blood transfusion. DENV was not screened regularly in Xishuangbanna Blood Center. This study was conducted in Xishuangbanna Blood Center with an attempt to develop DENV screening strategies in one of China’s high-incidence areas.METHODS Blood samples were collected randomly between June 2019 and August 2019. These samples were first screened for dengue IgG and IgM antibodies using enzyme-linked immunosorbent assay (ELISA). All reactive samples and some randomly-chosen non-reactive samples were used to detect DENV RNAs using real time polymerase-chain-reaction (RT-PCR) assay. After RT-PCR assay, these samples were further tested for soluble nonstructural protein 1 (NS1) using colloidal gold method. The demographic data of DENV positive donors were collected.RESULTS A total of 2,254 donor samples were collected and tested for dengue IgG and IgM antibodies by ELISA between June 2019 and August 2019. ELISA testing revealed that 598 donor samples were anti-IgG and/or anti-IgM reactive, with a serological prevalence rate of 26.53%. Among all the donor samples, 26 were RT-PCR positive and/or NS1 positive. Moreover, there were significant differences in the prevalence rate of DENV in terms of occupation (P=0.001), education(P<0.001) and ethnicity (P=0.026). CONCLUSION The prevalence of DENV in Xishuangbanna Blood Center was higher than most other blood centers that have implemented DENV donor screening. Our study provides the first-hand data about the prevalence of DENV and allows development of a screening strategy for clinical use.


2012 ◽  
Vol 58 (4) ◽  
pp. 552-554 ◽  
Author(s):  
Yoshiaki Hayashi ◽  
Yuki Naito ◽  
Mitsuaki Akino ◽  
Masako Katsumata ◽  
Chihiro Homma ◽  
...  

1987 ◽  
Vol 33 (5) ◽  
pp. 535-540
Author(s):  
S. Sekiguchi ◽  
T. Kimoto ◽  
A. Tamori ◽  
K. Higuchi ◽  
T. Kato ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document